These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8230819

  • 1. [Maintenance therapy on the anemia in continuous ambulatory peritoneal dialysis (CAPD) patients using subcutaneous administration of recombinant human erythropoietin fortnightly--a multicenter trial].
    Kubota M, Kawaguchi Y, Nomoto Y, Tsuchida H, Nihei H, Kubo K, Omori Y, Babazono T, Ogura Y, Hara S.
    Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1081-90. PubMed ID: 8230819
    [Abstract] [Full Text] [Related]

  • 2. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 Sep; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 3. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
    Abreo K, Lubom JA, Collier L, Fleming D, Work J.
    Adv Perit Dial; 1994 Sep; 10():124-8. PubMed ID: 7999809
    [Abstract] [Full Text] [Related]

  • 4. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 5. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D.
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R, Bloom E, Johnson R.
    Adv Perit Dial; 1993 May; 9():177-80. PubMed ID: 8105918
    [Abstract] [Full Text] [Related]

  • 7. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
    Goldraich I, Goldraich N.
    Adv Perit Dial; 1992 May; 8():440-3. PubMed ID: 1361843
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Once weekly subcutaneous erythropoietin is an effective maintenance therapy in the treatment of anemia of end stage renal disease in patients on CAPD.
    Saleh A, Krane NK, Caballero M, Starks E.
    Adv Perit Dial; 1991 May; 7():288-91. PubMed ID: 1680448
    [Abstract] [Full Text] [Related]

  • 10. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R, Bloom E, Johnson R, Goldstein M.
    Adv Perit Dial; 1994 May; 10():135-8. PubMed ID: 7999811
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
    Zelichowski G, Lubas A, Sienkiewicz M, Janusz E, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
    [Abstract] [Full Text] [Related]

  • 14. One year experience with subcutaneous human erythropoietin in CAPD: correction of renal anemia and increased ultrafiltration.
    Lubrich-Birkner I, Schollmeyer P, Steinhauer HB.
    Adv Perit Dial; 1990 Apr; 6():302-7. PubMed ID: 1982833
    [Abstract] [Full Text] [Related]

  • 15. The effect of subcutaneous recombinant human erythropoietin (r-Hu EPO) in CAPD patients with renal anaemia.
    Janicka L, Ksiazek A, Baranowicz I, Mierzicki P.
    Ann Univ Mariae Curie Sklodowska Med; 1994 Apr; 48 Suppl 3():67-77. PubMed ID: 8192534
    [Abstract] [Full Text] [Related]

  • 16. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y, Ito K.
    Adv Perit Dial; 1992 Apr; 8():448-52. PubMed ID: 1361845
    [Abstract] [Full Text] [Related]

  • 17. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M, Bartlett DK, Brier ME, Golper TA.
    Adv Perit Dial; 1993 Apr; 9():331-5. PubMed ID: 8105957
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A, Paoletti E, Molinelli G.
    Adv Perit Dial; 1990 Apr; 6():292-5. PubMed ID: 1982830
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.